AP2419A - Orally administrable antimalarial combined preparation and preparation process thereof. - Google Patents
Orally administrable antimalarial combined preparation and preparation process thereof.Info
- Publication number
- AP2419A AP2419A AP2005003402A AP2005003402A AP2419A AP 2419 A AP2419 A AP 2419A AP 2005003402 A AP2005003402 A AP 2005003402A AP 2005003402 A AP2005003402 A AP 2005003402A AP 2419 A AP2419 A AP 2419A
- Authority
- AP
- ARIPO
- Prior art keywords
- preparation
- antimalarial
- orally administrable
- combined
- preparation process
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title 2
- 230000000078 anti-malarial effect Effects 0.000 title 1
- 239000003430 antimalarial agent Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040088413A KR100623322B1 (ko) | 2004-11-02 | 2004-11-02 | 경구투여용 항말라리아 배합 제제 및 그의 제조방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
AP2419A true AP2419A (en) | 2012-06-05 |
Family
ID=36319369
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AP2005003402A AP2419A (en) | 2004-11-02 | 2005-09-29 | Orally administrable antimalarial combined preparation and preparation process thereof. |
Country Status (8)
Country | Link |
---|---|
KR (1) | KR100623322B1 (ko) |
CN (1) | CN101052392B (ko) |
AP (1) | AP2419A (ko) |
BR (1) | BRPI0517241B8 (ko) |
HK (1) | HK1113079A1 (ko) |
OA (1) | OA13155A (ko) |
WO (1) | WO2006049391A1 (ko) |
ZA (1) | ZA200703467B (ko) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101544638B (zh) * | 2009-05-12 | 2012-05-30 | 重庆通天药业有限公司 | 乳酸咯萘啶及其药物组合物 |
CN109640993B (zh) | 2016-08-12 | 2021-07-09 | 诺麦塔制药有限公司 | 包含阿莫地喹及抗糖尿病药物作为有效成分的用于预防或治疗糖尿病的药学组合物 |
JP2023519277A (ja) * | 2020-03-26 | 2023-05-10 | シンプン・ファーマシューティカル・カンパニー・リミテッド | 伝染性rnaウイルス感染症の予防又は治療するための医薬組成物 |
CN113350334A (zh) * | 2021-02-05 | 2021-09-07 | 中国中医科学院中药研究所 | 一种含有双氢青蒿素的抗疟药物 |
WO2022231238A1 (ko) * | 2021-04-26 | 2022-11-03 | 심민보 | 아르테수네이트 또는 그의 염, 및 피로나리딘 또는 그의 염의 해열, 항염증, 항바이러스용, 또는 covid-19 예방 또는 치료용 약학적 조성물 및 이를 이용한 방법 |
KR20230076573A (ko) | 2021-11-24 | 2023-05-31 | 장은혜 | 야생쑥 추출 천연 아르테미시닌을 함유한 항말라리아용 구강붕해성 필름제제 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1200925A (zh) * | 1997-05-30 | 1998-12-09 | 北京市科泰新技术公司 | 一种治疗抗药性恶性疟疾的药物组合物及其制备方法 |
-
2004
- 2004-11-02 KR KR1020040088413A patent/KR100623322B1/ko active IP Right Grant
-
2005
- 2005-09-29 AP AP2005003402A patent/AP2419A/xx active
- 2005-10-07 OA OA1200500281A patent/OA13155A/en unknown
- 2005-10-14 BR BRPI0517241A patent/BRPI0517241B8/pt active IP Right Grant
- 2005-10-14 WO PCT/KR2005/003432 patent/WO2006049391A1/en active Application Filing
- 2005-10-14 CN CN2005800374225A patent/CN101052392B/zh active Active
-
2007
- 2007-04-30 ZA ZA200703467A patent/ZA200703467B/xx unknown
-
2008
- 2008-03-05 HK HK08102530.5A patent/HK1113079A1/xx unknown
Non-Patent Citations (3)
Title |
---|
LIU ET AL: 'Study on treatment of multi-drug resistant falciparum malaria by using a combination of dihydroartemisinin and pyronaridine' ZHONGGUO JI SHENG CHONG XUE YU JI SHENG CHONG BING ZA ZHI vol. 20, no. 4, 2002, pages 193 - 196 * |
YANG ET AL: 'Effect of pyronaridine, mefloquine and quinine on artesunate-sensitive and artesunate resistant Plasmodium falciparum' ZHONGGUO JI SHENG CHONG XUE YU JI SHENG CHONG BANG ZA ZHI vol. 18, no. 1, 2000, pages 5 - 7 * |
ZHANG ET AL: 'Studies on the establishment of malarial animal model of short-term relapse. III. Combined therapy with pyronaridine-artemether-chloroquine for parasitemia clearance' ZHONGGUO JI SHENG CHONG XUE YU JI SHENG CHONG BING ZA ZHI vol. 11, no. 3, 1993, pages 180 - 184 * |
Also Published As
Publication number | Publication date |
---|---|
BRPI0517241A (pt) | 2008-10-07 |
BRPI0517241B1 (pt) | 2019-10-22 |
WO2006049391A1 (en) | 2006-05-11 |
KR20060039286A (ko) | 2006-05-08 |
BRPI0517241B8 (pt) | 2021-05-25 |
HK1113079A1 (en) | 2008-09-26 |
OA13155A (en) | 2006-12-13 |
ZA200703467B (en) | 2008-09-25 |
CN101052392B (zh) | 2010-12-15 |
CN101052392A (zh) | 2007-10-10 |
KR100623322B1 (ko) | 2006-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL175338A0 (en) | Orally administrable films and preparation thereof | |
EP1747775A4 (en) | DISPERSIBLE MONTMORILLONITE TABLET AND ITS MANUFACTURE | |
IL180706A0 (en) | Pharmaceutical dosage forms including rasagiline | |
ZA200704661B (en) | Solid, orally appliance pharmaceutical administration forms containing rivaroxaban having modified release | |
FI1765303T4 (fi) | Väärinkäytöltä suojattu oraalinen tabletti | |
AP2255A (en) | Irinotecan preparation. | |
EP1803446A4 (en) | MOUTH-CATCHING TABLET AND MANUFACTURING PROCESS | |
IL184288A0 (en) | 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same | |
IL228730A0 (en) | Pharmaceutical manufacturing process | |
EP1731139A4 (en) | PHARMACEUTICAL PREPARATION OF THE S / O TYPE AND MANUFACTURING METHOD THEREFOR | |
AP2419A (en) | Orally administrable antimalarial combined preparation and preparation process thereof. | |
HK1113686A1 (en) | Biotinylated hexadecasaccharides, preparation and use thereof | |
HK1105872A1 (en) | Orally dispersible pharmaceutical composition and process for the preparation thereof | |
AP2006003557A0 (en) | Antimalarial compositions and process thereof. | |
GB0424323D0 (en) | Tablet | |
IL183702A0 (en) | Difluoronucleosides and process for preparation thereof | |
ZA200704714B (en) | Integrated separation and preparation process | |
IL177759A0 (en) | Cospeptin, cosmedin and their uses | |
HK1100946A1 (en) | 1-a-HALO-2,2-DIFLUORO-2-DEOXY-D-RIBOFURANOSE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF | |
GB2418628B (en) | Improved laminates and the manufacture thereof | |
EP1781678A4 (en) | 1 -? - HALOGEN-2,2-DIFLUOR-2-DESOXY-D-RIBOFURANOSEDERIVATE AND PROCESS FOR THE PRODUCTION THEREOF | |
EP1716865A4 (en) | PHARMACEUTICAL PREPARATION CONTAINING PARAOXONASE | |
GB0408535D0 (en) | Insoluble drugs | |
AU2004906975A0 (en) | Daily dosage checker | |
AU2004902251A0 (en) | Reminder RX |